Overview


Driven by rising sleep disorders, wellness trends, and growing consumer focus on holistic sleep management, the Sleeping Aids Market comprises products and services designed to support, improve, or regulate sleep quality and duration, including OTC supplements, prescription therapies, wearable technology, and digital sleep-health solutions.

According to FutureWise analysis, the Sleeping Aids Market in 2026 is US$85.18 billion, and is expected to reach US$149.7 billion by 2036 at a CAGR of 5.80%. Market demand for sleep-related products is rising due to increased cases of sleep disorders like insomnia and sleep apnea, as well as growing stress levels and changing lifestyles. The expansion of the market can be significantly attributed to advancements in smart sleep devices and an increased awareness of the importance of sleep health.

Growth Drivers:

  • Rising prevalence of sleep disorders (insomnia, sleep apnea, etc.)
  • Increasing stress and lifestyle-related sleep issues
  • Growing awareness of sleep health and wellness
  • Expansion of OTC and natural sleep aid products
  • Adoption of digital sleep-tracking and wearable

Key Trends:

  • Growing popularity of natural and plant-based sleep aid products
  • Expansion of digital sleep tech and mobile health apps for personalised sleep management
  • Rising use of wearable devices to monitor and improve sleep patterns
  • Increased consumer preference for non-pharmacological and holistic sleep solutions
  • Surge in e-commerce sales and direct-to-consumer marketing for sleep aid products

Market Segmentation and Key Players:

The Sleeping Aids Market is segmented by product into mattresses & pillows, sleep laboratories, medications (including prescription and OTC drugs), and sleep apnea devices; by type of sleep disorders such as insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleepwalking, and others; and by region across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the Sleeping Aids Market include Cadwell Industries, Inc. and GlaxoSmithKline Plc, among others, driving innovation and market share globally.

Research Methodology:

The research methodology for the Sleeping Aids Market by FutureWise Research combines in-depth secondary research with primary interviews from industry experts and key stakeholders to ensure accurate market sizing and forecasting. The study applies data triangulation, market breakdown analysis, and validated assumptions to evaluate growth trends, competitive landscape, and regional dynamics, delivering reliable and data-driven market insights.

  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • GlaxoSmithKline Plc
  • MerckCo., Inc.
  • Natus Medical Inc.
  • Koninklijke Philips N.V.
  • PFIZER, INC.
  • Sanofi S.A.
  • SleepMed Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Sleeping Aids Market:

Cadwell Industries

Cadwell has incorporated EnsoData’s EnsoSleep AI scoring platform into its Easy III PSG and ApneaTrak HSAT systems. This integration achieves over 90% agreement in scoring, significantly reducing the workload for clinicians by automating sleep event scoring within minutes. As a result, healthcare providers can spend more time interacting with patients, ultimately enhancing lab efficiency.

Pfizer 

In early 2023, Pfizer, in collaboration with Neurogen, advanced NGD-96-3 into Phase I human trials. This investigational compound selectively targets specific GABA receptor subtypes, aiming to deliver sleep benefits while minimizing side effects commonly associated with traditional sleep medications, such as next-day drowsiness and the potential for dependency.

By Product

  • Mattresses and Pillows
  • Sleep Laboratories
  • Medications
    • Prescription-Based Drugs
    • OTC Drugs
  • Sleep Apnea Devices

By Sleep Disorders

  • Insomnia
  • Sleep Apnea
  • Restless Leg Syndrome
  • Narcolepsy
  • Sleepwalking
  • Other Sleep Disorders

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The sleeping aids market is anticipated to show substantial growth in the Asia Pacific region owing to the increasing prevalence of sleeping disorders, rise in the geriatric population in the region and surgical awareness regarding sleeping aids products.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global sleeping aids market by product, by sleep disorders and by Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Sleeping Aids Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Sleeping Aids Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Sleeping Aids Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Sleeping Aids Market, By Product Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Mattresses and Pillows
        2. Sleep Laboratories
        3. Medications
         3.1. Prescription-Based Drugs
         3.2. OTC Drugs
        4. Sleep Apnea Devices

  • 8.   Sleeping Aids Market, By Sleep Disorders Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Insomnia
        2. Sleep Apnea
        3. Restless Leg Syndrome
        4. Narcolepsy
        5. Sleepwalking
        6. Other Sleep Disorders

  • 9.   North America Sleeping Aids Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country,  2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 10.   Latin America Sleeping Aids Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country,  2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 11.   Europe Sleeping Aids Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 12.   Asia Pacific Sleeping Aids Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country,  2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 13.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country,  2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Cadwell Industries, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Compumedics Limited
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Drive DeVilbiss Healthcare Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. GlaxoSmithKline Plc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. MerckCo., Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Natus Medical Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Koninklijke Philips N.V.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
         8. PFIZER, INC.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sanofi S.A.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.SleepMed Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

FAQ


Key drug classes include benzodiazepines (e.g., GABA-A receptor modulators), non-benzodiazepine sedative-hypnotics (Z-drugs), melatonin receptor agonists, dual orexin receptor antagonists (DORAs), antidepressants used off-label, and antihistamines with sedative properties.

Related Market

Calming and Sleeping Market

Read More
Partner

Our Clients